Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-113496
Filing Date
2016-04-06
Accepted
2016-04-06 17:03:31
Documents
2
Period of Report
2016-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2220
2 POA DOCUMENT poa.txt EX-24.3_647710 3580
  Complete submission text file 0001209191-16-113496.txt   7293
Mailing Address C/O ONOTHYREON INC. 2601 4TH AVENUE, SUITE 500 SEATTLE WA 98121
Business Address
Myers Scott Dunseth (Reporting) CIK: 0001356256 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33882 | Film No.: 161558139

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research